Cite
HARVARD Citation
Goette, A. et al. (2016). Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. Lancet. 388 (10055), pp. 1995-2003. [Online].